Mark Lankisch

1.4k total citations
36 papers, 1.1k citations indexed

About

Mark Lankisch is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Mark Lankisch has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 12 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in Mark Lankisch's work include Cardiovascular Function and Risk Factors (14 papers), Cardiac Imaging and Diagnostics (7 papers) and Diabetes Treatment and Management (7 papers). Mark Lankisch is often cited by papers focused on Cardiovascular Function and Risk Factors (14 papers), Cardiac Imaging and Diagnostics (7 papers) and Diabetes Treatment and Management (7 papers). Mark Lankisch collaborates with scholars based in Germany, United States and Belarus. Mark Lankisch's co-authors include Reiner Füth, Wilfried Dinh, Thomas Scheffold, Werner Nickl, Werner A. Scherbaum, Michael Coll Barroso, Thomas Krahn, Eugene P. DiMagno, Alexander Bufe and Jack L. Leahy and has published in prestigious journals such as PLoS ONE, Diabetes Care and The American Journal of Gastroenterology.

In The Last Decade

Mark Lankisch

36 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Lankisch Germany 20 482 332 218 142 131 36 1.1k
H. Mayaudon France 14 205 0.4× 268 0.8× 176 0.8× 136 1.0× 181 1.4× 98 839
Chih‐Sheng Chu Taiwan 21 506 1.0× 182 0.5× 348 1.6× 245 1.7× 91 0.7× 71 1.2k
Angela Favuzzi Italy 15 302 0.6× 250 0.8× 191 0.9× 118 0.8× 172 1.3× 25 885
Dimitrios Tousoulis Greece 19 409 0.8× 203 0.6× 314 1.4× 138 1.0× 215 1.6× 43 1.1k
Celina Wojciechowska Poland 14 493 1.0× 125 0.4× 148 0.7× 125 0.9× 99 0.8× 53 899
J. Lekakis Greece 16 484 1.0× 144 0.4× 135 0.6× 115 0.8× 106 0.8× 43 991
Ľudovít Gašpar Slovakia 17 217 0.5× 175 0.5× 212 1.0× 255 1.8× 238 1.8× 92 967
Aaron Wong United Kingdom 11 316 0.7× 347 1.0× 241 1.1× 427 3.0× 157 1.2× 30 1.1k
Grzegorz Osmenda Poland 14 289 0.6× 108 0.3× 119 0.5× 210 1.5× 210 1.6× 21 1.1k
Kentaro Watanabe Japan 16 155 0.3× 258 0.8× 259 1.2× 134 0.9× 122 0.9× 132 989

Countries citing papers authored by Mark Lankisch

Since Specialization
Citations

This map shows the geographic impact of Mark Lankisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lankisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lankisch more than expected).

Fields of papers citing papers by Mark Lankisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lankisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lankisch. The network helps show where Mark Lankisch may publish in the future.

Co-authorship network of co-authors of Mark Lankisch

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lankisch. A scholar is included among the top collaborators of Mark Lankisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lankisch. Mark Lankisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lankisch, Mark, Stefano Del Prato, Marie‐Paule Dain, Peter R. Mullins, & David R. Owens. (2015). Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials. Primary care diabetes. 10(1). 51–59. 13 indexed citations
2.
Dinh, Wilfried, Reiner Füth, Mark Lankisch, et al.. (2011). Fator de diferenciação de crescimento 15: um novo biomarcador em pacientes com disfunção diastólica?. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 28 indexed citations
3.
Dinh, Wilfried, Reiner Füth, Mark Lankisch, et al.. (2011). Fator de diferenciação de crescimento 15: um novo biomarcador em pacientes com disfunção diastólica?. Arquivos Brasileiros de Cardiologia. 97(1). 65–75. 23 indexed citations
4.
Schinner, Sven, Reiner Füth, Kerstin Kempf, et al.. (2011). A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels. Cardiovascular Diabetology. 10(1). 56–56. 11 indexed citations
6.
Dinh, Wilfried, Mark Lankisch, Werner Nickl, et al.. (2010). Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study. Cardiovascular Diabetology. 9(1). 63–63. 70 indexed citations
8.
Sause, Armin, et al.. (2010). Limiting esophageal temperature in radiofrequency ablation of left atrial tachyarrhythmias results in low incidence of thermal esophageal lesions. BMC Cardiovascular Disorders. 10(1). 52–52. 41 indexed citations
10.
Dinh, Wilfried, Reiner Füth, Werner Nickl, et al.. (2009). Increased levels of laminin and collagen type VI may reflect early remodelling in patients with acute myocardial infarction. Acta Cardiologica. 64(3). 329–334. 19 indexed citations
11.
Dinh, Wilfried, Reiner Füth, Werner Nickl, et al.. (2009). Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovascular Diabetology. 8(1). 58–58. 121 indexed citations
13.
Scherbaum, Werner A., Christian Ohmann, Heinz‐Harald Abholz, Nico Dragano, & Mark Lankisch. (2008). Effect of the Frequency of Self-Monitoring Blood Glucose in Patients with Type 2 Diabetes Treated with Oral Antidiabetic Drugs—A Multi-Centre, Randomized Controlled Trial. PLoS ONE. 3(8). e3087–e3087. 37 indexed citations
14.
Rose, B., Mark Lankisch, K Röhrig, et al.. (2008). Beneficial Effects of External Muscle Stimulation on Glycaemic Control in Patients with Type 2 Diabetes. Experimental and Clinical Endocrinology & Diabetes. 116(10). 577–581. 8 indexed citations
15.
Lankisch, Mark, Reiner Füth, H Gülker, et al.. (2008). Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clinical Research in Cardiology. 97(10). 753–759. 37 indexed citations
16.
Lankisch, Mark, Reiner Füth, B. Rose, et al.. (2006). High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clinical Research in Cardiology. 95(2). 80–87. 31 indexed citations
17.
Klein, Richard M., Hong Jiang, Dieter Niederacher, et al.. (2004). Frequency and quantity of theparvovirus B19 genome in endomyocardial biopsies from patientswith suspected myocarditis or idiopathic left ventriculardysfunction. Zeitschrift für Kardiologie. 93(4). 300–309. 33 indexed citations
18.
Scherbaum, Werner A., et al.. (2002). Insulin Lispro in pregnancy - retrospective analysis of 33 cases and matched controls. Experimental and Clinical Endocrinology & Diabetes. 110(1). 6–9. 21 indexed citations
19.
Maringhini, Alberto, Mark Lankisch, Alan R. Zinsmeister, L. Joseph Melton, & Eugene P. DiMagno. (2000). Acute Pancreatitis in the Postpartum Period: A Population-Based Case-Control Study. Mayo Clinic Proceedings. 75(4). 361–364. 17 indexed citations
20.
Lankisch, Mark, Peter Layer, Robert A. Rizza, & Eugene P. DiMagno. (1998). Acute Postprandial Gastrointestinal and Metabolic Effects of Wheat Amylase Inhibitor (WAI) in Normal, Obese, and Diabetic Humans. Pancreas. 17(2). 176–181. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026